Allogeneic haematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with life-threating haematological disorders and the most successful cell replacement therapy developed to date with over 40,000 transplantations performed per year worldwide. Cord […]
On 20 December, Allergan and Paratek Pharmaceuticals announced that the FDA accepted a New Drug Application (NDA) to review Seysara (sarecycline) for the treatment of moderate-to-severe acne vulgaris in patients nine years of age and […]
Since it became clear that monoclonal antibodies and recombinant proteins will revolutionise the pharmaceutical industry, the interests of small, medium and large pharmaceutical companies in personalised medicine has grown rapidly. Biologics are set to dominate […]
Indicated for use in combination with other antiretroviral agents, atazanavir sulfate capsules act as a protease inhibitor for the treatment of HIV-1 infection for patients six years and older weighing at least 15kg. Teva North […]
Five months after blocking the products of Prosana Distribuciones from the U.S., the FDA has issued a warning letter for the Mexican company. The letter, which was issued December 18, follows an import alert for […]